Westphal Christoph H 4
4 · Flex Pharma, Inc. · Filed Jul 27, 2017
Insider Transaction Report
Form 4
Westphal Christoph H
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-07-26+12,000→ 12,000 totalExercise: $4.08Exp: 2027-07-26→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017.